Cargando…

Prescription of Lipid-Lowering and Antihypertensive Drugs Following Pictorial Information About Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial

IMPORTANCE: Preventive drugs are often underused. Carotid intima-media thickness and carotid plaques are associated with cardiovascular disease (CVD), and their detection could possibly improve estimation of the likelihood of CVD and prescription of preventive drugs. OBJECTIVE: To evaluate whether p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sjölander, Maria, Carlberg, Bo, Norberg, Margareta, Näslund, Ulf, Ng, Nawi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377571/ https://www.ncbi.nlm.nih.gov/pubmed/34410393 http://dx.doi.org/10.1001/jamanetworkopen.2021.21683

Ejemplares similares

The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial
por: Bengtsson, Anna, et al.
Publicado: (2021)

Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over
por: Holmberg, Henrik, et al.
Publicado: (2022)

Increased knowledge makes a difference! – general practitioners’ experiences of pictorial information about subclinical atherosclerosis for primary prevention: an interview study from the VIPVIZA trial
por: Bengtsson, Anna, et al.
Publicado: (2021)

Association of Physician Education and Feedback on Hypertension Management With Patient Blood Pressure and Hypertension Control
por: Brunström, Mattias, et al.
Publicado: (2020)

Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis
por: Bengtsson, Anna, et al.
Publicado: (2023)

Trends of blood pressure levels and management in Västerbotten County, Sweden, during 1990–2010
por: Ng, Nawi, et al.
Publicado: (2012)

Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)

Normal-weight obesity is associated with increased risk of subclinical atherosclerosis
por: Kim, Sohee, et al.
Publicado: (2015)

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study
por: Chevli, Parag Anilkumar, et al.
Publicado: (2021)

Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
por: Won, Ki-Bum, et al.
Publicado: (2013)

Associations Between Life-Course Lipid Trajectories and Subclinical Atherosclerosis in Midlife
por: Yan, Yinkun, et al.
Publicado: (2022)

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013)

Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes
por: Yoon, Hye Eun, et al.
Publicado: (2016)

Association of Childhood Oral Infections With Cardiovascular Risk Factors and Subclinical Atherosclerosis in Adulthood
por: Pussinen, Pirkko J., et al.
Publicado: (2019)

Recognition memory for pictorial material in subclinical depression
por: Ramponi, Cristina, et al.
Publicado: (2010)

The TANSNIP-PESA trial is not the end of the story
por: Näslund, Ulf, et al.
Publicado: (2023)

Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes
por: Carbonell, Marc, et al.
Publicado: (2018)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
por: Palanca, Ana, et al.
Publicado: (2019)

Cognitive and emotional reactions to pictorial-based risk communication on subclinical atherosclerosis: a qualitative study within the VIPVIZA trial
por: Andersson, Elin M., et al.
Publicado: (2023)

Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes
por: Weinstock, Ruth S., et al.
Publicado: (2023)

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
por: Xiao, Yang, et al.
Publicado: (2015)

Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients
por: Yayar, Özlem, et al.
Publicado: (2018)

Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
por: Colom, Cristina, et al.
Publicado: (2018)

Increasing physical activity, but persisting social gaps among middle-aged people: trends in Northern Sweden from 1990 to 2007
por: Ng, Nawi, et al.
Publicado: (2011)

A reversal of decreasing trends in population cholesterol levels in Västerbotten County, Sweden
por: Ng, Nawi, et al.
Publicado: (2012)

Who is using snus? - Time trends, socioeconomic and geographic characteristics of snus users in the ageing Swedish population
por: Norberg, Margareta, et al.
Publicado: (2011)

Serum sclerostin level and its relation to subclinical atherosclerosis in the polycystic ovary syndrome phenotypes: A prospective controlled study
por: İncesu Çintesun, Feyza Nur, et al.
Publicado: (2021)

Subclinical atherosclerosis: what it is, what it means and what we can do about it
por: Toth, P P
Publicado: (2008)

Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study
por: Lu, Ya-Wen, et al.
Publicado: (2021)

Waist Circumference and All-Cause Mortality among Older Adults in Rural Indonesia
por: Pujilestari, Cahya Utamie, et al.
Publicado: (2019)

Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population
por: Aguilera, Eva, et al.
Publicado: (2015)

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease
por: Oğuz, Didem, et al.
Publicado: (2016)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Prescription Pattern of Antihypertensive Drugs: An Experience from a Secondary Care Hospital in the United Arab Emirates
por: Alkaabi, Maryam Salem, et al.
Publicado: (2019)

Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
por: Tang, Bowen, et al.
Publicado: (2023)

Immediate Antihypertensive Treatment for Patients With Acute Ischemic Stroke With or Without History of Hypertension: A Secondary Analysis of the CATIS Randomized Clinical Trial
por: Zhang, Rui, et al.
Publicado: (2019)

Lower Zinc Bioavailability May Be Related to Higher Risk of Subclinical Atherosclerosis in Korean Adults
por: Jung, Su Kyoung, et al.
Publicado: (2013)

Comparative effects of lipid lowering, hypoglycemic, antihypertensive and antiplatelet medications on carotid artery intima-media thickness progression: a network meta-analysis
por: Huang, Rongzhong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dnofgf0bf94r950p1i202v8bam